Publication Cover
Inhalation Toxicology
International Forum for Respiratory Research
Volume 32, 2020 - Issue 3
198
Views
1
CrossRef citations to date
0
Altmetric
Research Articles

Global optimization of the Michaelis–Menten parameters using physiologically-based pharmacokinetic (PBPK) modeling and chloroform vapor uptake data in F344 rats

, , , &
Pages 97-109 | Received 16 Aug 2019, Accepted 08 Mar 2020, Published online: 02 Apr 2020

References

  • Andersen ME, Gargas ML, Clewell HJ, Severyn KM. 1987. Quantitative evaluation of the metabolic interactions between trichloroethylene and 1,1-dichloroethylene in vivo using gas uptake methods. Toxicol Appl Pharmacol. 89(2):149–157.
  • Andersen ME, Gargas ML, Jones RA, Jenkins LJ. 1980. Determination of the kinetic constants for metabolism of inhaled toxicants in vivo using gas uptake measurements. Toxicol Appl Pharmacol. 54(1):100–116.
  • Banga JR. 2008. Optimization in computational systems biology. BMC Syst Biol. 2(1):47.
  • Banga JR, Balsa-Canto E. 2008. Parameter estimation and optimal experimental design. Essays Biochem. 45:195–210.
  • Banks HT, Cintrón-Arias A, Kappel F. 2013. Parameter selection methods in inverse problem formulation. In Batzel JJ, Bachar M, Kappel F, editors. Mathematical modeling and validation in physiology. Basel (Switzerland): Springer; p. 43–73.
  • Banks HT, Ernstberger SL, Grove SL. 2007. Standard errors and confidence intervals in inverse problems: sensitivity and associated pitfalls. J Inv Ill-Posed Problems. 15(1):1–18.
  • Bonvin D, Georgakis C, Pantelides CC, Barolo M, Grover MA, Rodrigues D, Schneider R, Dochain D. 2016. Linking models and experiments. Ind Eng Chem Res. 55(25):6891–6903.
  • Caldwell JC, Evans MV, Krishnan K. 2012. Cutting edge PBPK models and analyses: providing the basis for future modeling efforts and bridges to emerging toxicology paradigms. J Toxicol. 2012:852384.
  • Cintrón-Arias A, Banks HT, Capaldi A, Lloyd AL. 2009. A sensitivity matrix methodology for inverse problem formulation. J Inv Ill-Posed Problems. 17(6):1–20.
  • Constan AA, Sprankle CS, Peters JM, Kedderis GL, Everitt JI, Wong BA, Gonzalez FL, Butterworth BE. 1999. Metabolism of chloroform by cytochrome P450 2E1 is required for induction of toxicity in the liver, kidney, and nose of male mice. Toxicol Appl Pharmacol. 160(2):120–126.
  • Corley RA, Mendrala AL, Smith FA, Staats DA, Gargas ML, Conolly RB, Andersen ME, Reitz RH. 1990. Development of a physiologically based pharmacokinetic model for chloroform. Toxicol Appl Pharmacol. 103(3):512–527.
  • Croom EL, Shafer TJ, Evans MV, Mundy WR, Eklund CR, Johnstone AFM, Mack CM, Pegram RA. 2015. Improving in vitro to in vivo extrapolation by incorporating toxicokinetic measurements: a case study of lindane-induced neurotoxicity. Toxicol Appl Pharmacol. 283(1):9–19.
  • Cuello WS, Janes TAT, Jessee JM, Venecek MA, Sawyer ME, Eklund CR, Evans MV. 2012. Physiologically based pharmacokinetic (PBPK) modeling of metabolic pathways of bromochloromethane in rats. J Toxicol. 2012:629781.
  • Delp MD, Evans MV, Duan C. 1998. Effects of aging on cardiac output, regional blood flow, and body composition in Fischer-344 rats. J Appl Physiol. 85(5):1813–1822.
  • Egea JA, Henriques D, Cokelaer T, Villaverde AF, MacNamara A, Danciu D-P, Banga JR, Saez-Rodriguez J. 2014. MEIGO: a software suite based on metaheuristics for global optimization in systems biology and bioinformatics. BMC Bioinform. 15:136.
  • Egea JA, Rodríguez-Fernández M, Banga JR, Martí R. 2007. Scatter search for chemical and bio-process optimization. J Glob Optim. 37(3):481–503.
  • Evans MV, Andersen ME. 1995. Sensitivity analysis and the design of gas uptake inhalation studies. Inhalation Toxicol. 7(7):1075–1094.
  • Evans MV, Caldwell JC. 2010. Evaluation of two different metabolic hypotheses for dichloromethane toxicity using physiologically based pharmacokinetic modeling for in vivo inhalation gas uptake data exposure in female B6C3F1 mice. Toxicol Appl Pharmacol. 244(3):280–290.
  • Evans MV, Crank WD, Yang HM, Simmons JE. 1994. Applications of sensitivity analysis to a physiologically based pharmacokinetic model for carbon tetrachloride in rats. Toxicol Appl Pharmacol. 128(1):36–44.
  • Filser JG. 1992. The closed chamber technique—uptake, endogenous production, excretion, steady-state kinetics and rates of metabolism of gases and vapors. Arch Toxicol. 66(1):1–10.
  • Filser JG, Kessler W, Csanády GA. 2004. The “Tuebingen Desiccator” system, a tool to study oxidative stress in vivo and inhalation toxicokinetics. Drug Metab Rev. 36(3–4):787–803.
  • Gargas ML, Andersen ME, Clewell HJ. 1986. A physiologically based simulation approach for determining metabolic constants from gas uptake data. Toxicol Appl Pharmacol. 86(3):341–352.
  • Gargas ML, Burgess RJ, Voisard DE, Cason GH, Andersen ME. 1989. Partition coefficients of low-molecular-weight volatile chemicals in various liquids and tissues. Toxicol Appl Pharmacol. 98(1):87–99.
  • Gargas ML, Clewell HJ, Andersen ME. 1990. Gas uptake inhalation techniques and the rates of metabolism of chloromethanes, chloroethanes, and chloroethylenes in the rat. Inhalation Toxicol. 2(3):295–319.
  • Garner CE, Liang S, Yin L, Yu X. 2015. Physiologically based pharmacokinetic modeling for 1-bromopropane in f344 rats using gas uptake inhalation experiments. Toxicol Sci. 145(1):23–36.
  • Gemma S, Vittozzi L, Testai E. 2003. Metabolism of chloroform in the human liver and identification of the competent P450s. Drug Metab Dispos. 31(3):266–274.
  • Goudar CT, Sonnad JR, Duggleby RG. 1999. Parameter estimation using a direct solution of the integrated Michaelis-Menten equation. Biochim Biophys Acta (BBA)-Prot Struct Mol Enzymol. 1429(2):377–383.
  • Guengerich FP, Kim DH, Iwasaki M. 1991. Role of human cytochrome P-450 IIE1 in the oxidation of many low molecular weight cancer suspects. Chem Res Toxicol. 4(2):168–179.
  • Haddad S, Tardif R, Charest-Tardif G, Krishnan K. 1999. Physiological modeling of the toxicokinetic interactions in a quaternary mixture of aromatic hydrocarbons. Toxicol Appl Pharmacol. 161(3):249–257.
  • Holmström K, Edvall MM. 1999. The TOMLAB optimization environment in Matlab. In Kallrath J, editor. Modeling languages in mathematical optimization. Basel (Swizerland): Springer; p. 369–376.
  • Johnson KA. 2019. New standards for collecting and fitting steady state kinetic data. Beilstein J Org Chem. 15(1):16–29.
  • McGee JK, Evans MV, Crank WD. 1995. A versatile gas uptake inhalation system used in pharmacokinetic and metabolic studies of volatile organic compounds. Toxicol Meth. 5(4):199–212.
  • McLean KAP, McAuley KB. 2012. Mathematical modelling of chemical processes—obtaining the best model predictions and parameter estimates using identifiability and estimability procedures. Can J Chem Eng. 90(2):351–366.
  • Moles CG, Mendes P, Banga JR. 2003. Parameter estimation in biochemical pathways: a comparison of global optimization methods. Genome Res. 13(11):2467–2474.
  • Rodriguez-Fernandez M, Egea JA, Banga JR. 2006. Novel metaheuristic for parameter estimation in nonlinear dynamic biological systems. BMC Bioinf. 7(1):483.
  • Sasso AF, Schlosser PM, Kedderis GL, Genter MB, Snawder JE, Li Z, Rieth S, Lipscomb JC. 2013. Application of an updated physiologically based pharmacokinetic model for chloroform to evaluate CYP2E1-mediated renal toxicity in rats and mice. Toxicol Sci. 131(2):360–374.
  • Sato A, Nakajima T. 1979. Partition coefficients of some aromatic hydrocarbons and ketones in water, blood and oil. Occup Environ Med. 36(3):231–234.
  • Segel IH. 1975. Enzyme kinetics. Vol. 360. New York (NY): Wiley.
  • Stroberg W, Schnell S. 2016. On the estimation errors of KM and V from time-course experiments using the Michaelis–Menten equation. Biophys Chem. 219:17–27.
  • Tardif R, Charest-Tardif G, Brodeur J, Krishnan K. 1997. Physiologically based pharmacokinetic modeling of a ternary mixture of alkyl benzenes in rats and humans. Toxicol Appl Pharmacol. 144(1):120–134.
  • Tardif R, Lapare S, Charest-Tardif G, Brodeur J, Krishnan K. 1995. Physiologically‐based pharmacokinetic modeling of a mixture of toluene and xylene in humans. Risk Anal. 15(3):335–342.
  • Testai E, De Curtis V, Gemma S, Fabrizi L, Gervasi P, Vittozzi L. 1996. The role of different cytochrome P450 isoforms in in vitro chloroform metabolism. J Biochem Toxicol. 11(6):305–312.
  • USEPA. 2005. Use of physiologically based pharmacokinetic models to quantify the impact of human age and interindividual differences in physiology and biochemistry pertinent to risk. Washington, DC: United States Environmental Protection Agency. EPA/600/R-06-014A.
  • Villaverde AF, Froehlich F, Weindl D, Hasenauer V, Banga JR.2019. Benchmarking optimization methods for parameter estimation in large kinetic models. Bioinformatics. 35(5):830–838.
  • Yao KZ, Shaw BM, Kou B, McAuley KB, Bacon DW. 2003. Modeling ethylene/butene copolymerization with multi‐site catalysts: parameter estimability and experimental design. Polym React Eng. 11(3):563–588.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.